The Sunset of the Part D Premium Stabilization Demonstration
A major development for beneficiaries with stand-alone Part D plans is the conclusion of the Part D Premium Stabilization Demonstration program. Federal officials originally introduced this temporary demonstration to cushion monthly premium increases after federal legislation overhauled out-of-pocket drug caps. However, federal authorities announced that this stabilization program will end for 2027. Consequently, beneficiaries in stand-alone Part D plans will likely see increases in their monthly drug plan premiums starting in 2027. While copayments for specific medications may fall due to price negotiations, baseline monthly plan fees may increase; this reality makes annual coverage comparisons crucial.
